Skip to content

Body Roundness Index and Mortality in ICU Patients

Body Roundness Index as a Predictor of Mortality in Adult Intensive Care Unit Patients: A Prospective Multicenter Cohort Study (BRI-ICU)

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07631429
Acronym
BRI-ICU
Enrollment
550
Registered
2026-06-08
Start date
2026-08-01
Completion date
2027-12-01
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Body Composition, Critical Illness, Mortality in Intensive Care Units, Obesity & Overweight

Keywords

Body Roundness Index, BRI, ICU mortality, Critical illness, Anthropometric measures, Central adiposity, BMI, Obesity paradox, Waist circumference

Brief summary

This study investigates whether Body Roundness Index (BRI), an anthropometric measure derived from waist circumference and height, can predict mortality in adult intensive care unit (ICU) patients. BRI captures central adiposity and body fat distribution more accurately than Body Mass Index (BMI). In this prospective multicenter cohort study, BRI will be measured at ICU admission and its association with ICU mortality, 28-day mortality, hospital mortality, mechanical ventilation duration, ICU length of stay, and acute kidney injury will be evaluated. The predictive performance of BRI will also be compared with BMI.

Detailed description

Body Roundness Index (BRI) is calculated using waist circumference and height, and reflects central adiposity more precisely than BMI. Despite growing evidence supporting BRI as a cardiovascular and metabolic risk predictor in general populations, its prognostic value in critically ill patients remains unexplored. In this prospective multicenter cohort study, adult patients admitted to participating ICUs will be enrolled. Waist circumference will be measured using a standardized protocol (supine position, iliac crest landmark, end-expiration, inelastic tape, 0.1 cm precision) within 24 hours of ICU admission. BRI will be calculated using the formula: 364.2 - 365.5 × √(1 - ((WC/2π)² / (0.5×height)²)). The primary outcome is ICU mortality. Secondary outcomes include 28-day mortality, hospital mortality, mechanical ventilation duration, ICU length of stay, and new acute kidney injury (KDIGO stage ≥2). The shape of the BRI-mortality relationship will be assessed using restricted cubic splines. BRI and BMI will be compared head-to-head for discriminative performance. Subgroup analyses will include sepsis patients to evaluate whether BRI resolves the obesity paradox observed with BMI.

Interventions

None listed

Sponsors

Ondokuz Mayıs University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥18 years * ICU admission with expected stay ≥24 hours * Waist circumference and height measurable within 24 hours of admission

Exclusion criteria

* Age \<18 years * ICU stay \<24 hours * Missing or unmeasurable anthropometric data (e.g., severe edema, abdominal wound, morbid obesity precluding measurement) * Pregnancy * Readmission (only first ICU admission included)

Design outcomes

Primary

MeasureTime frameDescription
ICU MortalityFrom ICU admission to ICU discharge or death, up to 28 days.Death occurring during ICU stay, assessed from admission to ICU discharge or death, whichever comes first.

Secondary

MeasureTime frameDescription
28-Day Mortality28 days from ICU admission.All-cause mortality within 28 days of ICU admission.
Hospital MortalityFrom ICU admission to hospital discharge or death, up to 90 days.Death occurring during hospital stay
Mechanical Ventilation DurationFrom ICU admission to ICU discharge, up to 28 days.Total days of invasive mechanical ventilation during ICU stay.
ICU Length of StayFrom ICU admission to ICU discharge, up to 28 days.Total number of days spent in the ICU
Number of Participants with New Acute Kidney Injury (KDIGO Stage ≥2)From ICU admission to ICU discharge, up to 28 days.New AKI development defined as KDIGO stage ≥2 during ICU stay.

Countries

Turkey (Türkiye)

Contacts

CONTACTÖzkul Yilmaz Çolak, MD
ozkulcolak@gmail.com+905063349266

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 9, 2026